Cargando…
A critical evaluation of TRPA1-mediated locomotor behavior in zebrafish as a screening tool for novel anti-nociceptive drug discovery
Current medications inadequately treat the symptoms of chronic pain experienced by over 50 million people in the United States, and may come with substantial adverse effects signifying the need to find novel treatments. One novel therapeutic target is the Transient Receptor Potential A1 channel (TRP...
Autores principales: | Ko, Mee Jung, Ganzen, Logan C., Coskun, Emre, Mukadam, Arbaaz A., Leung, Yuk Fai, van Rijn, Richard M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382835/ https://www.ncbi.nlm.nih.gov/pubmed/30787340 http://dx.doi.org/10.1038/s41598-019-38852-9 |
Ejemplares similares
-
2095 Drug screening and hit identification for night blindness with zebrafish
por: Ganzen, Logan, et al.
Publicado: (2018) -
2217: A transgenic retinitis pigmentosa zebrafish model for drug discovery
por: Ganzen, Logan, et al.
Publicado: (2018) -
Utilizing Zebrafish Visual Behaviors in Drug Screening for Retinal Degeneration
por: Ganzen, Logan, et al.
Publicado: (2017) -
Drug screening with zebrafish visual behavior identifies carvedilol as a potential treatment for an autosomal dominant form of retinitis pigmentosa
por: Ganzen, Logan, et al.
Publicado: (2021) -
Statistical Analysis of Zebrafish Locomotor Response
por: Liu, Yiwen, et al.
Publicado: (2015)